We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01724879
Recruitment Status : Completed
First Posted : November 12, 2012
Last Update Posted : February 11, 2016
Information provided by (Responsible Party):
Nicola Goekbuget, Johann Wolfgang Goethe University Hospitals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2015
  Study Completion Date : September 2015